MESOTHELIN-EXPRESSING ADVANCED CANCERS

Clinical trials for MESOTHELIN-EXPRESSING ADVANCED CANCERS explained in plain language.

Never miss a new study

Get alerted when new MESOTHELIN-EXPRESSING ADVANCED CANCERS trials appear

Sign up with your email to follow new studies for MESOTHELIN-EXPRESSING ADVANCED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental cancer drug trial halted after early testing

Disease control Terminated

This early-stage study tested whether a new drug called ZW171 was safe for people with advanced ovarian cancer, lung cancer, and other cancers that had spread. The trial enrolled 32 participants whose cancers had stopped responding to standard treatments. Researchers measured sid…

Matched conditions: MESOTHELIN-EXPRESSING ADVANCED CANCERS

Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

MESOTHELIN-EXPRESSING ADVANCED CANCERS

Get alerted when new MESOTHELIN-EXPRESSING ADVANCED CANCERS trials appear

Experimental cancer drug trial halted after early testing